Pulmonary Embolism News and Research

RSS

A pulmonary embolism is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung.

AI vs. clinical reports for the detection of incidental pulmonary embolus on chest CT

According to ARRS' American Journal of Roentgenology (AJR), an AI tool for detection of incidental pulmonary embolus (iPE) on conventional contrast-enhanced chest CT examinations had high NPV and moderate PPV for detection, even finding some iPEs missed by radiologists.

13 Jul 2022

Risk factors associated with shoulder surgery are low, but some need further surgery within a year

Rates of serious complications associated with shoulder surgery are low, but one in 26 patients need further surgery within a year, finds a study in The BMJ today.

7 Jul 2022

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

Scientists have provided a detailed overview on the long-term symptoms experienced by COVID-19 patients after initial primary infection with SARS-CoV-2.

30 Jun 2022

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

AbbVie today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ® 15 mg, once daily) for the treatment of active non-radiographic axial spondyloarthritis (nr‑axSpA) in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).*

27 Jun 2022

One in 500 men may carry an extra X or Y chromosome which could increase risk of several diseases

Around one in 500 men could be carrying an extra X or Y chromosome – most of them unaware – putting them at increased risk of diseases such as type 2 diabetes, atherosclerosis and thrombosis, say researchers at the universities of Cambridge and Exeter.

10 Jun 2022

The incidence of post-COVID conditions among patients who had received a previous COVID-19 diagnosis

Researchers evaluated the incidence of post-COVID-19 conditions among adults in the United States.

26 May 2022

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Patients who have suffered from a first episode of unprovoked venous thromboembolism (VTE) have an eight times higher risk of recurrence if they stop treatment after repeated negative D-dimer tests, instead of continuing with low-dose anticoagulant (apixaban).

20 May 2022

Incidence of arterial and venous thromboembolism and death in COVID-19 patients

Researchers estimated the incidence of arterial or venous thrombosis in patients with coronavirus disease 2019.

19 May 2022

Patients with COVID-19 pneumonitis and moderate to severe ARDS treated with sildenafil

A new study published in the British Journal of Anaesthesia aimed to determine whether sildenafil could improve gaseous exchange in patients with COVID-19 ARDS with pulmonary hypertension, RV dysfunction, or both.

17 May 2022

Study investigates COVID-19 vaccination in pregnancy

A new study discusses the risk of COVID-19-related complications in pregnancy and the role of vaccination in reducing this risk.

17 May 2022

Role of complement factor H-related protein 5 in venous thromboembolism and COVID-19

A new study discussed the role of complement factor H-related protein 5 (CFHR5) in venous thromboembolism (VTE) patients and hospitalized COVID-19 patients.

25 Apr 2022

Incidence of venous thromboembolism following COVID-19 vaccination

Researchers investigated the association between genetic predisposition to venous thromboembolism and increased risk of thrombosis post-COVID-19 vaccination.

22 Apr 2022

Cancer patients with non-O blood types face higher risk of developing blood clots

A new Blood Advances study suggests that people with cancer and non-O blood types, such as types A, B, and AB, face an increased risk of developing venous thromboembolism (VTE), or blood clots in the veins, three months after their initial diagnosis.

13 Apr 2022

COVID-19 increases risk of bleeding, DVT, and pulmonary embolism

...

11 Apr 2022

Study finds higher risk of thrombotic events after SARS-CoV-2 infection

A study from Sweden published by The BMJ today finds an increased risk of deep vein thrombosis (a blood clot in the leg) up to three months after covid-19 infection, pulmonary embolism (a blood clot in the lung) up to six months, and a bleeding event up to two months.

8 Apr 2022

Pulmonary Embolism News and Research

Further Reading

AI vs. clinical reports for the detection of incidental pulmonary embolus on chest CT

Risk factors associated with shoulder surgery are low, but some need further surgery within a year

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

One in 500 men may carry an extra X or Y chromosome which could increase risk of several diseases

The incidence of post-COVID conditions among patients who had received a previous COVID-19 diagnosis

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Incidence of arterial and venous thromboembolism and death in COVID-19 patients

Patients with COVID-19 pneumonitis and moderate to severe ARDS treated with sildenafil

Study investigates COVID-19 vaccination in pregnancy

Role of complement factor H-related protein 5 in venous thromboembolism and COVID-19

Incidence of venous thromboembolism following COVID-19 vaccination

Cancer patients with non-O blood types face higher risk of developing blood clots

COVID-19 increases risk of bleeding, DVT, and pulmonary embolism

Study finds higher risk of thrombotic events after SARS-CoV-2 infection

Clinical determinants of post-COVID-19 thromboembolism

Accurate detection of D-dimer for pulmonary embolism among ER patients with suspected COVID-19

The effect of SARS-CoV-2 infection on patients with a history of atrial fibrillation

Hazards of persistent and new clinical sequelae caused by SARS-CoV-2 infection among elderly patients

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News